{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

More MS in focus translations

MSIF is pleased to announce that MS in focus magazine continues to be translated into a wide variety of languages.

As well as German and Spanish editions of each issue, we are delighted that Issue 1 on fatigue is now available in Dutch. Thank you to the MS Society of The Netherlands, Stichting MS Research, who undertook the translation, design and print of this edition. Please click here to download a copy.

We are also pleased that Issues 3 (cognition and emotions) and 4 (family) have recently been translated and printed in Italian. To download copies, please click here.

MSIF welcomes three new members of the Persons with MS International Committee

MSIF is delighted to welcome Uma Aaltonen (Finland), Ellen Boyd (USA) and Fabiana Pérez Montañés (Uruguay) to the Persons with MS International Committee.

read more

MSIF Charcot Award 2007

Every two years, MSIF gives the Charcot Award for a lifetime achievement in outstanding research into the understanding of, or treatment of MS. Nominations for the 2007 award are now open (closing date: 20 December, 2006).

read more

Are your contact details right?

We are currently checking and updating the contact details of MS societies listed on WoMS, our website. Are your details correct?

read more

back to top

Profile of the Month : January 2008

Meg Kingston

Country: Wales
Age: 40-something
Year of diagnosis: late 1990s
Occupation: writer and former IT consultant

English Italiano Deutsh Espanol Francais Russian

read more

back to top

Multiple sclerosis: a battle between destruction and repair

This review covers what is known about the pathology of MS and addresses potential mechanisms of regeneration and repair that could be manipulated by treatment. It includes a paragraph on the potential of stem cells.

authors: McQualter JL, Bernard CC

source: J Neurochem. 2006 Nov 13; [Epub ahead of print]

read more

Genetics of autoimmune neuroinflammation

This review article considers the complex genetics of human MS and its animal model and some of the reasons for the difficulties in identifying candidate genes.

authors: Olsson T, Jagodic M, Piehl F, Wallstrom E.

source: Curr Opin Immunol. 2006 Dec;18(6):643-9. Epub 2006 Sep 14.

read more

Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology

A review of some of the cellular mechanisms of myelination. Improved understanding in this area could lead to better treatments for demyelination.

authors: Butt AM.

source: Glia. 2006 Nov 15;54(7):666-75.

read more

Sleep-wake and body core temperature rhythms in multiple sclerosis with fatigue

Fatigue in MS is incompletely understood. This study concludes that it is not due to abnormal sleep behaviour.

authors: Vetrugno R, Stecchi S, Scandellari C, Pierangeli G, Sabattini L, D'Angelo R, Provini F, Plazzi G, Cortelli P, Montagna P.

source: Clin Neurophysiol. 2006 Nov 7; [Epub ahead of print]

read more

back to top

MS debate in EU petitions committee successful

source: European Multiple Sclerosis Platform

The "2nd European MS Awareness Day" organised by the European MS Platform (EMSP) at the European Parliament in Brussels on 21 November 2006, was extremely successful and effective. More than 20 MEPs gave assurances of their support in the fight to improve the lives of people with MS, and the Petitions Committee decided to seek an open question time session on MS in the European Parliament.

read more

UK health trusts told MS drugs must be funded

source: UK MS Society

The UK Government's Department of Health has told NHS trusts that they must continue to fund disease modifying drugs – the beta interferons and glatiramer acetate – for people with MS who stand to benefit.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.